Company profile
Nanalysis Scientific Corp.
OTC: NSCIF · Healthcare · Medical - Specialties
Canadian filerHQ Calgary, ABReports USD
#509 of 1,418 Healthcare companies by revenue30th-percentile growth
EA Score
59CFH 62DQ —GM 49SS 58
v0.1 · 45/100 weight · provisional
↑ workforce scale, return on assets · ↓ listing tenure, revenue growth (YoY)
Methodology →Revenue TTM
$29.2M
Rev growth YoY (TTM)
-5.2%
Net income (FY)
-$4.0M
Employees
15,299
as of 2026-08-22
Market cap
$14.9M
as of 2026-08-22
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$28.7M40.1M CAD2025
Net income-$4.0M-5.7M CAD2025
Operating income-$2.7M-3.8M CAD2025
Total assets$28.0M38.4M CAD2025
Liabilities$18.2M25.0M CAD2025
Equity$9.8M13.4M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Nanalysis Scientific Corp.’s revenue?
Nanalysis Scientific Corp. booked $28.7M in FY2025 revenue, contracting 14% year over year — slower than 70% of Healthcare companies we track, at a -14.1% net margin.
Peers · Healthcare
Scilex Holding Company28DDelota Corp.——IMRIS Inc.——Oscar Health, Inc.50DBionano Genomics, Inc.48DLowell Farms Inc.——Key facts
CEOSean Krakiwsky
SectorHealthcare
IndustryMedical - Specialties
HeadquartersCalgary, AB
ExchangeOTC: NSCIF
Employees15,299
IPO date2020-04-16
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.